Part 3: Endoscopic injection versus antibiotic prophylaxis in the reduction of urinary tract infections in patients with vesicoureteral reflux

ABSTRACT Objective: Vesicoureteral reflux (VUR) occurs in approximately 1% of infants and children and is associated with recurrent urinary tract infections (UTIs). The objective of this paper is to examine the use of endoscopic injection with dextranomer/hyaluronic acid copolymer (Dx/HA) as a curat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Current medical research and opinion 2007-01, Vol.23 (S4), p.S15-S20
Hauptverfasser:	Elder, Jack S., Shah, Manan B., Batiste, LaKeasha R., Eaddy, Michael
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Bacterial Agents - administration & dosage Child Child, Preschool Databases, Factual Deflux Dextranomer/hyaluronic acid copolymer Dextrans - administration & dosage Dx/HA Endoscopic injection Female Humans Hyaluronic Acid - administration & dosage Infant Infant, Newborn Male Retrospective Studies Ureteroscopy Urinary tract infection Urinary Tract Infections - etiology Urinary Tract Infections - prevention & control UTI Vesico-Ureteral Reflux - complications Vesico-Ureteral Reflux - drug therapy Vesicoureteral reflux VUR
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	ABSTRACT Objective: Vesicoureteral reflux (VUR) occurs in approximately 1% of infants and children and is associated with recurrent urinary tract infections (UTIs). The objective of this paper is to examine the use of endoscopic injection with dextranomer/hyaluronic acid copolymer (Dx/HA) as a curative option and as an alternative to antibiotic prophylaxis, as Dx/HA is gaining in popularity in the treatment of VUR. Methods: The nationally representative PharMetrics Integrated Medical and Pharmaceutical database was used to conduct this retrospective analysis. Patients
ISSN:	0300-7995 1473-4877
DOI:	10.1185/030079907X226230